| Viatris Pharma GmbH - Inhixa 8000 IE (80 mg), Injektionslösung |
| 67454 | | 04 | | Inhixa 8000 IE (80 mg) | | Injektionslösung | | B01AB05 | | Enoxaparin | | 10.06.2020 | | |
|
| Composition |
| enoxaparinum natricum 80 mg corresp. 8000 U.I. anti-Xa, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 0.47 mmol. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Enoxaparin Sodium | 80 mg |
| | BAG: Active Agent | Dose |
|---|
| Enoxaparin Sodium | 80 mg |
| | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 010 | 2 | | | B | | Yes | | 011 | 10 | 52.47 | 73.50 | B | SL | No | | 012 | 50 | | | B | | Yes |
|
